CEO Angel Stanz Email #4
*Angel didn't state much here but was willing and offered to talk almost 2 years ago of the state of affairs.
On Jun 16, 2012, at 5:52 PM, BN wrote:
> June 16, 2012
> Dear Mr. Stanz,
> First, let me welcome you to the helm as CEO of BG Medical Technologies. I’m a firm believer in the critical distinction between ownership vs. leadership of a company. It is refreshing to not only have you as the leader in the reverse merger activities with RightSmile, Inc. but as the one who led the startup of BudGenius.
> As a shareholder, I have several questions that hopefully you could provide some answers to.
> For more than 6 months now, I have watched the stock price of RIGH rise and fall between .0008c - .0001c. Since March 1st, BGMT’s stock has plummeted from a high of .0006c to the lower lows of .0002c. It is very clear, there has been considerable manipulation of the stock to the downside for far too long. What is management’s opinion of this debacle and what is your plan to overcome this manipulation? Is there any concerns or abnormal delays with the symbol and name change?
> Sometimes business ventures end up successful but there is considerable turmoil along the way. In the December 2011 Conference Call, Randy Schneider, RightSmile’s Chairman/CEO, specifically stated “...he had no intention of utilizing the remaining outstanding shares of RIGH,” yet he did just the opposite prior to handing over the reigns to you. I respect anyone’s opinion if it is backed up by facts, but those remarks were deceitful and damaging to not only you, but to the shareholders of BG Medical Technologies, as well. I view his actions as bad judgment and a one-sided attempt to compensate for his lack of leadership and failures as outgoing CEO. Actions speak louder than words. What are BG management and the board of director’s action plan for overcoming this destructive path led by Mr. Schneider?
> As a long-time investor and market follower, I have a grave concern with BG Medical Technologies facing the current and upcoming market head winds. I believe RIGH faced this market turmoil once before. Another downturn in the economy could conceivable impact everything again: from MMJ testing, to potential M&A activity (or partnerships) and the markets impact on the long-term PPS. What are management’s and the boards plan to raise both the short-term and long-term PPS to acceptable levels? How, if the markets are plunging do you intend to tender potential acquisition companies who then switch to preserving their capital? What is the goal to keep BG Medical attractive even through market turbulence?
> I am a 22-year veteran of the U.S. Air Force. One of the items that attracted me most to BG Medical Technologies was to bring further light to the medical efficacy of cannabis. There are numerous war veterans that suffer from PTSD. The potential for treatment of battlefield or unit trauma for products in this sector is paramount. Are there ongoing public relations with government officials, such as the military or American Red Cross? Or is this not a company initiative?
> As a community member and a leader in a former fortune 50 company, I realize the painstaking tribulations in successfully turning around and restoring shareholder confidence. What are your top #5 agenda items for lifting the PPS and turning BGMT to profitability status? What is your timeframe for successful completion of those goals? Do you plan to share BGMT’s financial information dating back to BudGenius/BG Medical Technologies inception (more than 12 months)? I ask, because I also follow ongoing activities of both Cannabis Science (CBIS) and Medical Marijuana, Inc. (MJNA)...
> MJNA filed an in-depth quarterly financial report, that was both easy-to-read (and impressive). If you have not reviewed this PR (by MJNA), I encourage you to do so; I believe it would be beneficial to both BGMT and shareholders to replicate in kind:
> http://finance.yahoo.com/news/medical-marijua...00062.html
> I am one of five large shareholders that I continuously correspond with who have been patiently waiting for the real value of BGMT to finally materialize. The reigns from RIGH are now in your hands and look forward to the name and symbol change. I have followed your trends in the music and technology industries on how you brought product attention-to-detail successfully to market. I have the confidence this can be done once again, with BGMT.
> I am of the understanding many of these questions cannot be directly answered to me. I raise them more so to bring awareness in hopes they may be addressed publicly in at some point in a PR.
> My best wishes to you and your staff, and I look forward to hearing from you!
> Sincerely,
> BN
..............
From: (Angel) BG MedTech <angel@bgmedtech.com>
To: ***********************.com>
Sent: Wednesday, June 20, 2012 3:42 PM
Subject: Re: Thank You!
BN,
Thank you for your well stated message.
Please do not interpret my delayed response as disinterest. I appreciate your concerns and will address them. Expect a reply from me before the end of week. Also, if you'd like, we can set up a time next week to have a chat. Is there a particular time frame that works best for you?
Warm Regards,
Angel Stanz, CEO
BG Medical Technologies, Inc.
RightSmile, Inc.
*************
*Angel didn't state much here but was willing and offered to talk almost 2 years ago of the state of affairs.
On Jun 16, 2012, at 5:52 PM, BN wrote:
> June 16, 2012
> Dear Mr. Stanz,
> First, let me welcome you to the helm as CEO of BG Medical Technologies. I’m a firm believer in the critical distinction between ownership vs. leadership of a company. It is refreshing to not only have you as the leader in the reverse merger activities with RightSmile, Inc. but as the one who led the startup of BudGenius.
> As a shareholder, I have several questions that hopefully you could provide some answers to.
> For more than 6 months now, I have watched the stock price of RIGH rise and fall between .0008c - .0001c. Since March 1st, BGMT’s stock has plummeted from a high of .0006c to the lower lows of .0002c. It is very clear, there has been considerable manipulation of the stock to the downside for far too long. What is management’s opinion of this debacle and what is your plan to overcome this manipulation? Is there any concerns or abnormal delays with the symbol and name change?
> Sometimes business ventures end up successful but there is considerable turmoil along the way. In the December 2011 Conference Call, Randy Schneider, RightSmile’s Chairman/CEO, specifically stated “...he had no intention of utilizing the remaining outstanding shares of RIGH,” yet he did just the opposite prior to handing over the reigns to you. I respect anyone’s opinion if it is backed up by facts, but those remarks were deceitful and damaging to not only you, but to the shareholders of BG Medical Technologies, as well. I view his actions as bad judgment and a one-sided attempt to compensate for his lack of leadership and failures as outgoing CEO. Actions speak louder than words. What are BG management and the board of director’s action plan for overcoming this destructive path led by Mr. Schneider?
> As a long-time investor and market follower, I have a grave concern with BG Medical Technologies facing the current and upcoming market head winds. I believe RIGH faced this market turmoil once before. Another downturn in the economy could conceivable impact everything again: from MMJ testing, to potential M&A activity (or partnerships) and the markets impact on the long-term PPS. What are management’s and the boards plan to raise both the short-term and long-term PPS to acceptable levels? How, if the markets are plunging do you intend to tender potential acquisition companies who then switch to preserving their capital? What is the goal to keep BG Medical attractive even through market turbulence?
> I am a 22-year veteran of the U.S. Air Force. One of the items that attracted me most to BG Medical Technologies was to bring further light to the medical efficacy of cannabis. There are numerous war veterans that suffer from PTSD. The potential for treatment of battlefield or unit trauma for products in this sector is paramount. Are there ongoing public relations with government officials, such as the military or American Red Cross? Or is this not a company initiative?
> As a community member and a leader in a former fortune 50 company, I realize the painstaking tribulations in successfully turning around and restoring shareholder confidence. What are your top #5 agenda items for lifting the PPS and turning BGMT to profitability status? What is your timeframe for successful completion of those goals? Do you plan to share BGMT’s financial information dating back to BudGenius/BG Medical Technologies inception (more than 12 months)? I ask, because I also follow ongoing activities of both Cannabis Science (CBIS) and Medical Marijuana, Inc. (MJNA)...
> MJNA filed an in-depth quarterly financial report, that was both easy-to-read (and impressive). If you have not reviewed this PR (by MJNA), I encourage you to do so; I believe it would be beneficial to both BGMT and shareholders to replicate in kind:
> http://finance.yahoo.com/news/medical-marijua...00062.html
> I am one of five large shareholders that I continuously correspond with who have been patiently waiting for the real value of BGMT to finally materialize. The reigns from RIGH are now in your hands and look forward to the name and symbol change. I have followed your trends in the music and technology industries on how you brought product attention-to-detail successfully to market. I have the confidence this can be done once again, with BGMT.
> I am of the understanding many of these questions cannot be directly answered to me. I raise them more so to bring awareness in hopes they may be addressed publicly in at some point in a PR.
> My best wishes to you and your staff, and I look forward to hearing from you!
> Sincerely,
> BN
..............
From: (Angel) BG MedTech <angel@bgmedtech.com>
To: ***********************.com>
Sent: Wednesday, June 20, 2012 3:42 PM
Subject: Re: Thank You!
BN,
Thank you for your well stated message.
Please do not interpret my delayed response as disinterest. I appreciate your concerns and will address them. Expect a reply from me before the end of week. Also, if you'd like, we can set up a time next week to have a chat. Is there a particular time frame that works best for you?
Warm Regards,
Angel Stanz, CEO
BG Medical Technologies, Inc.
RightSmile, Inc.
*************
